Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 10;9(4):e5045.
doi: 10.17795/ijcp-5045. eCollection 2016 Aug.

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia

Affiliations

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia

Abolghasem Allahyari et al. Iran J Cancer Prev. .

Abstract

Background: Acute lymphoblastic leukemia (ALL) is aggressive cancer, especially in adults as only 20-40% is cured with current treatment regimens.

Objectives: The aim of this study is to evaluate prognostic factors and their effects on survival in ALL patients in the Northeast of Iran.

Methods: In a descriptive and retrospective study from 2009 to 2015, 48 ALL patients referred to hematology-oncology clinic. Age, sex, fever, blood group, type of ALL and consumption of amphotericin B, forms of cytogenetic, survival in the patients, WBC, hemoglobin, and platelet were checked in the first referral for every patient. The mean follow-up was 27.3 months in which 28 patients (59.3%) died. overall survival (OS) was plotted by GraphPad Prism 5 and the Log-rank test was used for analysis of survival with risk factors.

Results: The mean age for all the ALL patients at diagnosis was 32.3 years (range, 15-71 years), and 81.3% were male. Of all patients, 62.5% had fever and 25% consumed amphotericin B. 1-, 2-, 3-, 4-, 5-year OS rates were 62.2%, 52.7%, 40.6%, 39.1%, 22.2%, respectively. 75%, 29.2% and 39.6% of patients had WBC < 20 × 103/μl, Hb < 7 g/dL and platelet < 30 × 103/μL, respectively. There was a significant difference in survival based on age (P = 0.000).

Conclusions: Based on the results, age > 35 years is the most prognostic factor in ALL patients. Also, patients who received amphotericin B had lower life expectancy because these patients were suffering from fungal infection or due to lack of response to antibacterial drugs, they have been treated with amphotericin B.

Keywords: Acute Lymphoblastic Leukemia; Age, Northeastern Iran; Survival; WBC.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:There is no conflict of interest.

Figures

Figure 1.
Figure 1.. The Kaplan-Meier Survival Curve Based on Risk Factors
Figure 2.
Figure 2.. The Kaplan-Meier Survival Curve Based on Risk Factors

Similar articles

References

    1. Levitt L, Lin R. Biology and treatment of adult acute lymphoblastic leukemia. West J Med. 1996;164(2):143–55. - PMC - PubMed
    1. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50(3):185–96. doi: 10.1053/j.seminhematol.2013.06.007. - DOI - PMC - PubMed
    1. Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, et al. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e5045. doi: 10.1371/journal.pone.0085554. - DOI - PMC - PubMed
    1. Ahmed MB, Shehata HH, Moussa M, Ibrahim TM. Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia. Clin Biochem. 2012;45(1-2):112–6. doi: 10.1016/j.clinbiochem.2011.08.1147. - DOI - PubMed
    1. Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Semin Hematol. 2009;46(1):64–75. doi: 10.1053/j.seminhematol.2008.09.003. - DOI - PubMed

LinkOut - more resources